17.44
0.00%
+0.00
Swk Holdings Corp stock is currently priced at $17.44, with a 24-hour trading volume of 3,920.
It has seen a +0.00% increased in the last 24 hours and a +2.53% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $17.41 pivot point. If it approaches the $17.47 resistance level, significant changes may occur.
Previous Close:
$17.44
Open:
$17.67
24h Volume:
3,920
Market Cap:
$220.57M
Revenue:
$37.76M
Net Income/Loss:
$15.89M
P/E Ratio:
12.46
EPS:
1.4
Net Cash Flow:
$14.39M
1W Performance:
+1.99%
1M Performance:
+2.53%
6M Performance:
+7.92%
1Y Performance:
+0.00%
Swk Holdings Corp Stock (SWKH) Company Profile
Name
Swk Holdings Corp
Sector
Industry
Phone
972 687 7250
Address
14755 Preston Road, Suite 105, Dallas
Swk Holdings Corp Stock (SWKH) Financials Data
Swk Holdings Corp (SWKH) Revenue 2024
SWKH reported a revenue (TTM) of $37.76 million for the quarter ending December 31, 2023, a -8.98% decline year-over-year.
Swk Holdings Corp (SWKH) Net Income 2024
SWKH net income (TTM) was $15.89 million for the quarter ending December 31, 2023, a +17.76% increase year-over-year.
Swk Holdings Corp (SWKH) Cash Flow 2024
SWKH recorded a free cash flow (TTM) of $14.39 million for the quarter ending December 31, 2023, a +82.05% increase year-over-year.
Swk Holdings Corp (SWKH) Earnings per Share 2024
SWKH earnings per share (TTM) was $1.26 for the quarter ending December 31, 2023, a +21.15% growth year-over-year.
About Swk Holdings Corp
SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.
Cap:
|
Volume (24h):